Acrolein-mediated injury in nervous system trauma and diseases

Molecular Nutrition and Food Research

Volumn 55, Issue 9, 2011, Pages 1320-1331

  Shi, Riyi ^a,b   Rickett, Todd ^b,c   Sun, Wenjing ^d  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Acrolein; Multiple sclerosis; Oxidative stress; Secondary injury; Spinal cord injury

Indexed keywords

ACROLEIN;

ANIMAL; CENTRAL NERVOUS SYSTEM; DRUG EFFECT; HUMAN; METABOLISM; MITOCHONDRION; MULTIPLE SCLEROSIS; MYELIN SHEATH; NERVOUS SYSTEM INJURY; REVIEW; SPINAL CORD INJURY;

ACROLEIN; ANIMALS; CENTRAL NERVOUS SYSTEM; HUMANS; MITOCHONDRIA; MULTIPLE SCLEROSIS; MYELIN SHEATH; SPINAL CORD INJURIES; TRAUMA, NERVOUS SYSTEM;

EID: 80052542264     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201100217     Document Type: Review

References (137)

1. Hall, E. D., Braughler, J. M., Central nervous system trauma and stroke II. Physiological and pharmacological evidence for involvement of oxygen radicals and lipid peroxidation. Free Radic. Biol. Med. 1989, 6, 303-313.
2. Hall, E. D., Lipid peroxidation. Adv. Neurol. 1996, 71, 247-257; discussion 257-258.
3. Halliwell, B., Gutteridge, J. M. C., Free Radicals in Biology and Medicine, Oxford University Press, Oxford 1999.
4. Hall, E. D., Yonkers, P. A., Andrus, P. K., Cox, J. W. et al., Biochemistry and pharmacology of lipid antioxidants in acute brain and spinal cord injury. J. Neurotrauma 1992, 9, S425-S442.
5. Hall, E. D., Free radicals and CNS injury. Crit. Care Clin. 1989, 5, 793-805.
6. Smith, K. J., Kapoor, R., Felts, P. A., Demyelination: the role of reactive oxygen and nitrogen species. Brain Pathol. 1999, 9, 69-92.
7. Lovell, M. A., Xie, C., Markesbery, W. R., Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiol. Aging 2001, 22, 187-194.
8. Lovell, M. A., Xie, C., Markesbery, W. R., Acrolein, a product of lipid peroxidation, inhibits glucose and glutamate uptake in primary neuronal cultures. Free Radic. Biol. Med. 2000, 29, 714-720.
9. Luo, J., Shi, R., Acrolein disrupts neuronal membrane in isolated guinea pig spinal cord. Soc. Neurosci. Abst. 2002, 28.
10. Luo, J., Shi, R., Acrolein induces axolemmal disruption, oxidative stress, and mitochondrial impairment in spinal cord tissue. Neurochem. Int. 2004, 44, 475-486.
11. Shi, R., Luo, J., Peasley, M. A., Acrolein inflicts axonal membrane disruption and conduction loss in isolated guinea pig spinal cord. Neuroscience 2002, 115, 337-340.
12. Williams, T. I., Lynn, B. C., Markesbery, W. R., Lovell, M. A., Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease. Neurobiol. Aging 2005, 27, 1094-1099.
13. Leung, G., Sun, W., Zheng, L., Brookes, S. et al., Anti-acrolein treatment improves behavioral outcome and alleviates myelin damage in experimental autoimmune enchephalomyelitis mouse. Neuroscience 2011, 173, 150-155.
14. Uchida, K., Kanematsu, M., Morimitsu, Y., Osawa, T. et al., Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins. J. Biol. Chem. 1998, 273, 16058-16066.
15. Luo, J., Shi, R., Acrolein induces oxidative stress in brain mitochondria. Neurochem. Int. 2005, 46, 243-252.
16. Ghilarducci, D. P., Tjeerdema, R. S., Fate and effects of acrolein. Rev. Environ. Contam. Toxicol. 1995, 144, 95-146.
17. Luo, J., Uchida, K., Shi, R., Accumulation of acrolein-protein adducts after traumatic spinal cord injury. Neurochem. Res. 2005, 30, 291-295.
18. Feng, Z., Hu, W., Hu, Y., Tang, M. S., Acrolein is a major cigarette-related lung cancer agent: Preferential binding at p53 mutational hotspots and inhibition of DNA repair. Proc. Natl. Acad. Sci. USA 2006, 103, 15404-15409.
19. Burcham, P. C., Raso, A., Thompson, C. A., Toxicity of smoke extracts towards A549 lung cells: role of acrolein and suppression by carbonyl scavengers. Chem. Biol. Interact. 2010, 183, 416-424.
20. Magnusson, R., Nilsson, C., Andersson, B., Emissions of aldehydes and ketones from a two-stroke engine using ethanol and ethanol-blended gasoline as fuel. Environ. Sci. Technol. 2002, 36, 1656-1664.
21. Ho, S. S., Yu, J. Z., Chu, K. W., Yeung, L. L., Carbonyl emissions from commercial cooking sources in Hong Kong. J. Air Waste Manag. Assoc. 2006, 56, 1091-1098.
22. Esterbauer, H., Schaur, R. J., Zollner, H., Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 1991, 11, 81-128.
23. Kehrer, J. P., Biswal, S. S., The molecular effects of acrolein. Toxicol. Sci. 2000, 57, 6-15.
24. Stevens, J. F., Maier, C. S., Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease. Mol. Nutr. Food Res. 2008, 52, 7-25.
25. Dennis, K. J., Shibamoto, T., Gas chromatographic analysis of reactive carbonyl compounds formed from lipids upon UV-irradiation. Lipids 1990, 25, 460-464.
26. Uchida, K., Current status of acrolein as a lipid peroxidation product. Trends Cardiovasc. Med. 1999, 9, 109-113.
27. Burcham, P. C., Pyke, S. M., Hydralazine inhibits rapid acrolein-induced protein oligomerization: role of aldehyde scavenging and adduct trapping in cross-link blocking and cytoprotection. Mol. Pharmacol. 2006, 69, 1056-1065.
28. Witz, G., Biological interactions of alpha, beta-unsaturated aldehydes. Free Radic. Biol. Med. 1989, 7, 333-349.
29. Adams, J. D., Jr., Klaidman, L. K., Acrolein-induced oxygen radical formation. Free Radic. Biol. Med. 1993, 15, 187-193.
30. Burcham, P. C., Fontaine, F. R., Kaminskas, L. M., Petersen, D. R. et al., Protein adduct-trapping by hydrazinophthalazine drugs: mechanisms of cytoprotection against acrolein-mediated toxicity. Mol. Pharmacol. 2004, 65, 655-664.
31. Kaminskas, L. M., Pyke, S. M., Burcham, P. C., Reactivity of hydrazinophthalazine drugs with the lipid peroxidation products acrolein and crotonaldehyde. Org. Biomol. Chem. 2004, 2, 2578-2584.
32. Mitchell, D. Y., Petersen, D. R., Metabolism of the glutathione-acrolein adduct, S-(2-aldehydo-ethyl)glutathione, by rat liver alcohol and aldehyde dehydrogenase. J. Pharmacol. Exp. Ther. 1989, 251, 193-198.
33. O'Brien, P. J., Siraki, A. G., Shangari, N., Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health. Crit. Rev. Toxicol. 2005, 35, 609-662.
34. Picklo, M. J., Montine, T. J., Acrolein inhibits respiration in isolated brain mitochondria. Biochim. Biophys. Acta 2001, 1535, 145-152.
35. Pocernich, C. B., Cardin, A. L., Racine, C. L., Lauderback, C. M. et al., Glutathione elevation and its protective role in acrolein-induced protein damage in synaptosomal membranes: relevance to brain lipid peroxidation in neurodegenerative disease. Neurochem. Int. 2001, 39, 141-149.
36. Logan, M. P., Parker, S., Shi, R., Glutathione and ascorbic acid enhance recovery of Guinea pig spinal cord white matter following ischemia and acrolein exposure. Pathobiology 2005, 72, 171-178.
37. Luo, J., Robinson, J. P., Shi, R., Acrolein-induced cell death in PC12 cells: role of mitochondria-mediated oxidative stress. Neurochem. Int. 2005, 47, 449-457.
38. Vander Jagt, D. L., Hunsaker, L. A., Vander Jagt, T. J., Gomez, M. S. et al., Inactivation of glutathione reductase by 4-hydroxynonenal and other endogenous aldehydes. Biochem. Pharmacol. 1997, 53, 1133-1140.
39. Fitzpatrick, M. O., Maxwell, W. L., Graham, D. I., The role of the axolemma in the initiation of traumatically induced axonal injury [editorial]. J. Neurol. Neurosurg. Psychiatry 1998, 64, 285-287.
40. Shi, R., Blight, A. R., Compression injury of mammalian spinal cord in vitro and the dynamics of action potential conduction failure. J. Neurophysiol. 1996, 76, 1572-1580.
41. Shi, R., Pryor, J. D., Pathological changes of isolated spinal cord axons in response to mechanical stretch. Neuroscience 2002, 110, 765-777.
42. Luo, J., Borgens, R. B., Shi, R., Polyethylene glycol immediately repairs neuronal membranes and inhibits free radical production after acute spinal cord injury. J. Neurochem. 2002, 83, 471-480.
43. Shi, R., Asano, T., Vining, N. C., Blight, A. R., Control of membrane sealing in injured mammalian spinal cord axons. J. Neurophysiol. 2000, 84, 1763-1769.
44. Shi, R., Pryor, J. D., Temperature dependence of membrane sealing following transection in mammalian spinal cord axons. Neuroscience 2000, 98, 157-166.
45. Shi, R., Qiao, X., Emerson, N., Malcom, A., Dimethylsulfoxide enhances CNS neuronal plasma membrane resealing after injury in low temperature or low calcium. J. Neurocytol. 2001, 30, 829-839.
46. Povlishock, J. T., Erb, D. E., Astruc, J., Axonal response to traumatic brain injury: reactive axonal change, deafferentation, and neuroplasticity. J. Neurotrauma 1992, 9, S189-S200.
47. Povlishock, J. T., Traumatically induced axonal injury: pathogenesis and pathobiological implications. Brain Pathol. 1992, 2, 1-12.
48. Christman, C. W., Grady, M. S., Walker, S. A., Holloway, K. L. et al., Ultrastructural studies of diffuse axonal injury in humans. J. Neurotrauma 1994, 11, 173-186.
49. Shi, R., The dynamics of axolemmal disruption in guinea pig spinal cord following compression. J. Neurocytol. 2004, 33, 203-211.
50. Hamann, K., Nehrt, G., Ouyang, H., Duerstock, B. et al., Hydralazine inhibits compression and acrolein-mediated injuries in ex vivo spinal cord. J. Neurochem. 2008, 104, 708-718.
51. Baldwin, S. A., Broderick, R., Osbourne, D., Waeg, G. et al., The presence of 4-hydroxynonenal/protein complex as an indicator of oxidative stress after experimental spinal cord contusion in a rat model. J. Neurosurg. 1998, 88, 874-883.
52. Springer, J. E., Azbill, R. D., Mark, R. J., Begley, J. G. et al., 4-hydroxynonenal, a lipid peroxidation product, rapidly accumulates following traumatic spinal cord injury and inhibits glutamate uptake. J. Neurochem. 1997, 68, 2469-2476.
53. Vaishnav, R. A., Singh, I. N., Miller, D. M., Hall, E. D., Lipid peroxidation-derived reactive aldehydes directly and differentially impair spinal cord and brain mitochondrial function. J. Neurotrauma 2010, 27, 1311-1320.
54. Cadenas, E., Davies, K. J., Mitochondrial free radical generation, oxidative stress, and aging. Free Radic. Biol. Med. 2000, 29, 222-230.
55. Lenaz, G., Bovina, C., D'Aurelio, M., Fato, R. et al., Role of mitochondria in oxidative stress and aging. Ann. NY Acad. Sci. 2002, 959, 199-213.
56. Boveris, A., Chance, B., The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem. J. 1973, 134, 707-716.
57. Biagini, R. E., Toraason, M. A., Lynch, D. W., Winston, G. W., Inhibition of rat heart mitochondrial electron transport in vitro: implications for the cardiotoxic action of allylamine or its primary metabolite, acrolein. Toxicology 1990, 62, 95-106.
58. Mavelli, I., Rigo, A., Federico, R., Ciriolo, M. R. et al., Superoxide dismutase, glutathione peroxidase and catalase in developing rat brain. Biochem. J. 1982, 204, 535-540.
59. Bai, J., Cederbaum, A. I., Mitochondrial catalase and oxidative injury. Biol. Signals Recept. 2001, 10, 189-199.
60. Esposito, L. A., Melov, S., Panov, A., Cottrell, B. A. et al., Mitochondrial disease in mouse results in increased oxidative stress. Proc. Natl. Acad. Sci. USA 1999, 96, 4820-4825.
61. Wallace, D. C., Mitochondrial diseases in man and mouse. Science 1999, 283, 1482-1488.
62. Wallace, D. C., Mouse models for mitochondrial disease. Am. J. Med. Genet. 2001, 106, 71-93.
63. Klingenberg, M., Nelson, D. R., Structure-function relationships of the ADP/ATP carrier. Biochim. Biophys. Acta 1994, 1187, 241-244.
64. Fiore, C., Trezeguet, V., Le Saux, A., Roux, P. et al., The mitochondrial ADP/ATP carrier: structural, physiological and pathological aspects. Biochimie 1998, 80, 137-150.
65. +: implications for neurodegeneration. J. Neurochem. 1994, 63, 584-591.
66. Lewen, A., Matz, P., Chan, P. H., Free radical pathways in CNS injury. J. Neurotrauma 2000, 17, 871-890.
67. Starkov, A. A., Polster, B. M., Fiskum, G., Regulation of hydrogen peroxide production by brain mitochondria by calcium and Bax. J. Neurochem. 2002, 83, 220-228.
68. Zamzami, N., Kroemer, G., The mitochondrion in apoptosis: how Pandora's box opens. Nat. Rev. Mol. Cell Biol. 2001, 2, 67-71.
69. Cohen, G., Farooqui, R., Kesler, N., Parkinson disease: a new link between monoamine oxidase and mitochondrial electron flow. Proc. Natl. Acad. Sci. USA 1997, 94, 4890-4894.
70. Compston, A., Coles, A., Multiple sclerosis. Lancet 2008, 372, 1502-1517.
71. Gold, R., Linington, C., Lassmann, H., Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 2006, 129, 1953-1971.
72. Totoiu, M. O., Keirstead, H. S., Spinal cord injury is accompanied by chronic progressive demyelination. J. Comp. Neurol. 2005, 486, 373-383.
73. Blight, A. R., Delayed demyelination and macrophage invasion: a candidate for secondary cell damage in spinal cord injury. Cent. Nerv. Syst. Trauma 1985, 2, 299-315.
74. Blight, A. R., Morphometric analysis of a model of spinal cord injury in guinea pigs, with behavioral evidence of delayed secondary pathology. J. Neurol. Sci. 1991, 103, 156-171.
75. Blight, A. R., in: Seil, F. J. (Ed.), Advances in Neurology, Vol. 59. Neural Injury and Regeneration, Raven Press, New York 1993, pp. 91-104.
76. Ouyang, H., Sun, W., Fu, Y., Li, J. et al., Compression induces acute demyelination and potassium channel exposure in spinal cord. J. Neurotrauma 2010, 27, 1109-1120.
77. Shi, Y., Sun, W., McBride, J. J., Cheng, J. X. et al., Acrolein induces myelin damage in mammalian spinal cord. J. Neurochem. 2011, 117, 554-564.
78. Jensen, J. M., Shi, R., Effects of 4-aminopyridine on stretched mammalian spinal cord: the role of potassium channels in axonal conduction. J. Neurophysiol. 2003, 90, 2334-2340.
79. Shi, R., Blight, A. R., Differential effects of low and high concentrations of 4-aminopyridine on axonal conduction in normal and injured spinal cord. Neuroscience 1997, 77, 553-562.
80. Shi, R., Kelly, T. M., Blight, A. R., Conduction block in acute and chronic spinal cord injury: different dose-response characteristics for reversal by 4-Aminopyridine. Exp. Neurol. 1997, 148, 495-501.
81. Sun, W., Smith, D., Fu, Y., Cheng, J. X. et al., Novel potassium channel blocker, 4-AP-3-MeOH, inhibits fast potassium channels and restores axonal conduction in injured guinea pig spinal cord white matter. J. Neurophysiol. 2010, 103, 469-478.
82. Leung, G., Sun, W., Brookes, S., Smith, D. et al., Potassium channel blocker, 4-aminopyridine-3-methanol, restores axonal conduction in spinal cord of an animal model of multiple sclerosis. Exp. Neurol. 2011, 227, 232-235.
83. Hains, B. C., Saab, C. Y., Lo, A. C., Waxman, S. G., Sodium channel blockade with phenytoin protects spinal cord axons, enhances axonal conduction, and improves functional motor recovery after contusion SCI. Exp. Neurol. 2004, 188, 365-377.
84. Shields, D. C., Tyor, W. R., Deibler, G. E., Hogan, E. L. et al., Increased calpain expression in activated glial and inflammatory cells in experimental allergic encephalomyelitis. Proc. Natl. Acad. Sci. USA 1998, 95, 5768-5772.
85. Boggs, J. M., Myelin basic protein: a multifunctional protein. Cell. Mol. Life Sci. 2006, 63, 1945-1961.
86. Readhead, C., Takasashi, N., Shine, H. D., Saavedra, R. et al., Role of myelin basic protein in the formation of central nervous system myelin. Ann. NY Acad. Sci. 1990, 605, 280-285.
87. Omlin, F. X., Webster, H. D., Palkovits, C. G., Cohen, S. R., Immunocytochemical localization of basic protein in major dense line regions of central and peripheral myelin. J. Cell Biol. 1982, 95, 242-248.
88. Poliak, S., Peles, E., The local differentiation of myelinated axons at nodes of Ranvier. Nat. Rev. Neurosci. 2003, 4, 968-980.
89. Rios, J. C., Melendez-Vasquez, C. V., Einheber, S., Lustig, M. et al., Contactin-associated protein (Caspr) and contactin form a complex that is targeted to the paranodal junctions during myelination. J. Neurosci. 2000, 20, 8354-8364.
90. Einheber, S., Zanazzi, G., Ching, W., Scherer, S. et al., The axonal membrane protein Caspr, a homologue of neurexin IV, is a component of the septate-like paranodal junctions that assemble during myelination. J. Cell Biol. 1997, 139, 1495-1506.
91. Tao-Cheng, J. H., Rosenbluth, J., Axolemmal differentiation in myelinated fibers of rat peripheral nerves. Brain Res. 1983, 285, 251-263.
92. Menegoz, M., Gaspar, P., Le Bert, M., Galvez, T. et al., Paranodin, a glycoprotein of neuronal paranodal membranes. Neuron 1997, 19, 319-331.
93. Denisenko-Nehrbass, N., Oguievetskaia, K., Goutebroze, L., Galvez, T. et al., Protein 4. 1B associates with both Caspr/paranodin and Caspr2 at paranodes and juxtaparanodes of myelinated fibres. Eur. J. Neurosci. 2003, 17, 411-416.
94. Ogawa, Y., Schafer, D. P., Horresh, I., Bar, V. et al., Spectrins and ankyrinB constitute a specialized paranodal cytoskeleton. J. Neurosci. 2006, 26, 5230-5239.
95. Kontrogianni-Konstantopoulos, A., Frye, C. S., Benz, E. J. Jr., Huang, S. C., The prototypical 4. 1R-10-kDa domain and the 4. 1g-10-kDa paralog mediate fodrin-actin complex formation. J. Biol. Chem. 2001, 276, 20679-20687.
96. Liu-Snyder, P., McNally, H., Shi, R., Borgens, R. B., Acrolein-mediated mechanisms of neuronal death. J. Neurosci. Res. 2006, 84, 209-218.
97. Goll, D. E., Thompson, V. F., Li, H., Wei, W. et al., The calpain system. Physiol. Rev. 2003, 83, 731-801.
98. Wang, K. K., Calpain and caspase: can you tell the difference? Trends Neurosci. 2000, 23, 20-26.
99. Sherratt, R. M., Bostock, H., Sears, T. A., Effects of 4-aminopyridine on normal and demyelinated mammalian nerve fibers. Nature 1980, 283, 570-572.
100. Dupree, J. L., Girault, J. A., Popko, B., Axo-glial interactions regulate the localization of axonal paranodal proteins. J. Cell Biol. 1999, 147, 1145-1152.
101. Wolswijk, G., Balesar, R., Changes in the expression and localization of the paranodal protein Caspr on axons in chronic multiple sclerosis. Brain 2003, 126, 1638-1649.
102. Shi, R., Borgens, R. B., Acute repair of crushed guinea pig spinal cord by polyethylene glycol. J. Neurophysiol. 1999, 81, 2406-2414.
103. Sakata, K., Kashiwagi, K., Sharmin, S., Ueda, S. et al., Acrolein produced from polyamines as one of the uraemic toxins. Biochem. Soc. Trans. 2003, 31, 371-374.
104. Togashi, M., Urano, Y., Kojima, H., Terai, T. et al., Sensitive detection of acrolein in serum using time-resolved luminescence. Org. Lett. 2010, 12, 1704-1707.
105. Liu-Snyder, P., Borgens, R. B., Shi, R., Hydralazine rescues PC12 cells from acrolein-mediated death. J. Neurosci. Res. 2006, 84, 219-227.
106. Nardini, M., Finkelstein, E. I., Reddy, S., Valacchi, G. et al., Acrolein-induced cytotoxicity in cultured human bronchial epithelial cells. Modulation by alpha-tocopherol and ascorbic acid. Toxicology 2002, 170, 173-185.
107. Sakata, K., Kashiwagi, K., Sharmin, S., Ueda, S. et al., Increase in putrescine, amine oxidase, and acrolein in plasma of renal failure patients. Biochem. Biophys. Res. Commun. 2003, 305, 143-149.
108. Hall, E. D., Wolf, D. L., Post-traumatic spinal cord ischemia: relationship to injury severity and physiological parameters. Cent. Nerv. Syst. Trauma 1987, 4, 15-25.
109. Sandler, A. N., Tator, C. H., Review of the effect of spinal cord trama on the vessels and blood flow in the spinal cord. J. Neurosur. 1976, 45, 638-646.
110. White, B. C., Sullivan, J. M., DeGracia, D. J., O'Neil, B. J. et al., Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J. Neurol. Sci. 2000, 179, 1-33.
111. Peasley, M. A., Shi, R., Ischemic insult exacerbates acrolein-induced conduction loss and axonal membrane disruption in guinea pig spinal cord white matter. J. Neurol. Sci. 2003, 216, 23-32.
112. Facchinetti, F., Amadei, F., Geppetti, P., Tarantini, F. et al., Alpha, beta-unsaturated aldehydes in cigarette smoke release inflammatory mediators from human macrophages. Am. J. Respir. Cell Mol. Biol. 2007, 37, 617-623.
113. Park, Y. S., Taniguchi, N., Acrolein induces inflammatory response underlying endothelial dysfunction: a risk factor for atherosclerosis. Ann. NY Acad. Sci. 2008, 1126, 185-189.
114. Barger, S. W., Goodwin, M. E., Porter, M. M., Beggs, M. L., Glutamate release from activated microglia requires the oxidative burst and lipid peroxidation. J. Neurochem. 2007, 101, 1205-1213.
115. Hamann, K., Durkes, A., Ouyang, H., Uchida, K. et al., Critical role of acrolein in secondary injury following ex vivo spinal cord trauma. J. Neurochem. 2008, 107, 712-721.
116. Toklu, H. Z., Hakan, T., Celik, H., Biber, N. et al., Neuroprotective effects of alpha-lipoic acid in experimental spinal cord injury in rats. J. Spinal Cord Med. 2010, 33, 401-409.
117. Luo, J., Borgens, R., Shi, R., Polyethylene glycol improves function and reduces oxidative stress in synaptosomal preparations following spinal cord injury. J. Neurotrauma 2004, 21, 994-1007.
118. Luo, J., Shi, R., Diffusive oxidative stress following acute spinal cord injury in guinea pigs and its inhibition by polyethylene glycol. Neurosci. Lett. 2004, 359, 167-170.
119. Burcham, P. C., Kerr, P. G., Fontaine, F., The antihypertensive hydralazine is an efficient scavenger of acrolein. Redox Rep. 2000, 5, 47-49.
120. Burcham, P. C., Kaminskas, L. M., Fontaine, F. R., Petersen, D. R. et al., Aldehyde-sequestering drugs: tools for studying protein damage by lipid peroxidation products. Toxicology 2002, 181-182, 229-236.
121. Kaminskas, L. M., Pyke, S. M., Burcham, P. C., Strong protein adduct trapping accompanies abolition of acrolein-mediated hepatotoxicity by hydralazine in mice. J. Pharmacol. Exp. Ther. 2004, 310, 1003-1010.
122. Wang, H., Manicke, N. E., Yang, Q., Zheng, L. et al., Direct analysis of biological tissue by paper spray mass spectrometry. Anal. Chem. 2011, 83, 1197-1201.
123. Gurney, A. M., Allam, M., Inhibition of calcium release from the sarcoplasmic reticulum of rabbit aorta by hydralazine. Br. J. Pharmacol. 1995, 114, 238-244.
124. Bang, L., Nielsen-Kudsk, J. E., Gruhn, N., Trautner, S. et al., Hydralazine-induced vasodilation involves opening of high conductance Ca2+-activated K+channels. Eur. J. Pharmacol. 1998, 361, 43-49.
125. Khan, M. A., Effect of hydralazine in hypertension. Br. Med. J. 1953, 1, 27-29.
126. Pandit, R. B., Long term propranolol and hydralazine in hypertension. J. Assoc. Physicians India 1984, 32, 199-202.
127. Physicians' Desk Reference, 54th Edn, Medical Economics Company, Montvale, NJ 2000.
128. Talseth, T., Studies on hydralazine. III. Bioavailability of hydralazine in man. Eur. J. Clin. Pharmacol. 1976, 10, 395-401.
129. Wood, P. L., Khan, M. A., Moskal, J. R., Todd, K. G. et al., Aldehyde load in ischemia-reperfusion brain injury: neuroprotection by neutralization of reactive aldehydes with phenelzine. Brain. Res. 2006, 1122, 184-190.
130. Nardil, Pfizer. New York, NY, 2009.
131. Reece, P. A., Hydralazine and related compounds: chemistry, metabolism, and mode of action. Med. Res. Rev. 1981, 1, 73-96.
132. Sheehan, D. V., Claycomb, J. B., Kouretas, N., Monoamine oxidase inhibitors: prescription and patient management. Int. J. Psychiatry Med. 1980, 10, 99-121.
133. Halliwell, B., Reactive oxygen species and the central nervous system. J. Neurochem. 1992, 59, 1609-1623.
134. Halliwell, B., Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 2001, 18, 685-716.
135. Hall, E. D., Braughler, J. M., Free radicals in CNS injury. Res. Publ. Assoc. Res. Nerv. Mental Dis. 1993, 71, 81-105.
136. Kontos, H. A., Povlishock, J. T., Oxygen radicals in brain injury. Cent. Nerv. Syst. Trauma 1986, 3, 257-263.
137. Povlishock, J. T., Kontos, H. A., The role of oxygen radicals in the pathobiology of traumatic brain injury. Human Cell 1992, 5, 345-353.